SBH
TMDX icon

Segall Bryant & Hamill’s Transmedics TMDX Stock Holding History

Segall Bryant & Hamill’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-111,121
Closed -$6.93M – 635
2024
Q4 		$6.93M Sell
111,121
-1,496
-1% -$139K 0.1% 282
2024
Q3 		$17.7M Sell
112,617
-4,599
-4% -$709K 0.24% 133
2024
Q2 		$17.7M Buy
117,216
+3,188
+3% +$382K 0.31% 101
2024
Q1 		$8.43M Buy
114,028
+19,789
+21% +$1.63M 0.16% 220
2023
Q4 		$7.44M Buy
94,239
+36,646
+64% +$2.21M 0.14% 227
2023
Q3 		$3.15M Buy
+57,593
New +$4.15M 0.04% 374

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Segall Bryant & Hamill's TMDX Position: Q1 2025 in Review

Segall Bryant & Hamill sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 111,121 shares — an estimated $6.93M sold.

Segall Bryant & Hamill first reported a position in TMDX in Q3 2023 and held it in 6 quarters. The position peaked at $17.7M in Q3 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Segall Bryant & Hamill reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Segall Bryant & Hamill sold 111,121 Transmedics shares in Q1 2025, an estimated $6.93M.
  • Segall Bryant & Hamill first reported a position in Transmedics in Q3 2023 and held it in 6 quarters.
  • Segall Bryant & Hamill's Transmedics position peaked at $17.7M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Segall Bryant & Hamill's 13F filing for Q1 2025, filed 2 May 2025.